Cullen/Frost Bankers, Inc. Pfizer Inc Transaction History

Cullen/Frost Bankers, Inc.

$7.23 Billion
Q3 2024

A detailed history of Cullen/Frost Bankers, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 419,510 shares of PFE stock, worth $11.1 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

419,510

Previous 436,823 3.96%

Holding current value

$11.1 Million

Previous $12.2 Million 0.67%

% of portfolio

0.17%

Previous 0.18%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$27.7 - $31.39 $479,570 - $543,455	-17,313 Reduced 3.96%	419,510 $12.1 Million
Q2 2024 Aug 05, 2024	SELL	$25.26 - $29.6 $3.54 Million - $4.15 Million	-140,266 Reduced 24.31%	436,823 $12.2 Million
Q1 2024 May 10, 2024	BUY	$25.89 - $29.73 $881,217 - $1.01 Million	34,037 Added 6.27%	577,089 $16 Million
Q4 2023 Feb 06, 2024	SELL	$26.13 - $33.94 $1.53 Million - $1.99 Million	-58,539 Reduced 9.73%	543,052 $15.6 Million
Q3 2023 Nov 02, 2023	SELL	$32.09 - $37.51 $46,209 - $54,014	-1,440 Reduced 0.24%	601,591 $20 Million
Q2 2023 Aug 04, 2023	SELL	$36.12 - $41.79 $187,065 - $216,430	-5,179 Reduced 0.85%	603,031 $22.1 Million
Q1 2023 May 05, 2023	BUY	$39.39 - $51.28 $461,335 - $600,591	11,712 Added 1.96%	608,210 $24.8 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $2.81 Million - $3.67 Million	67,316 Added 12.72%	596,498 $30.6 Million
Q3 2022 Nov 07, 2022	BUY	$43.76 - $53.42 $717,226 - $875,553	16,390 Added 3.2%	529,182 $23.2 Million
Q2 2022 Aug 05, 2022	BUY	$46.53 - $55.17 $373,031 - $442,297	8,017 Added 1.59%	512,792 $26.9 Million
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $487,008 - $603,465	10,645 Added 2.15%	504,775 $26.1 Million
Q4 2021 Feb 07, 2022	SELL	$41.32 - $61.25 $369,566 - $547,820	-8,944 Reduced 1.78%	494,130 $29.2 Million
Q3 2021 Nov 04, 2021	BUY	$39.25 - $50.42 $431,200 - $553,914	10,986 Added 2.23%	503,074 $21.6 Million
Q2 2021 Aug 05, 2021	BUY	$35.91 - $40.68 $4.75 Million - $5.38 Million	132,363 Added 36.8%	492,088 $19.3 Million
Q1 2021 May 05, 2021	BUY	$33.49 - $37.77 $21,366 - $24,097	638 Added 0.18%	359,725 $13 Million
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $124,608 - $158,450	-3,723 Reduced 1.03%	359,087 $13.2 Million
Q3 2020 Nov 05, 2020	BUY	$31.75 - $37.25 $17,589 - $20,636	554 Added 0.15%	362,810 $13.3 Million
Q2 2020 Aug 05, 2020	BUY	$30.12 - $36.54 $923,238 - $1.12 Million	30,652 Added 9.24%	362,256 $11.8 Million
Q1 2020 May 01, 2020	BUY	$27.03 - $38.62 $1.04 Million - $1.48 Million	38,379 Added 13.09%	331,604 $10.8 Million
Q4 2019 Feb 06, 2020	BUY	$32.92 - $37.36 $1.09 Million - $1.23 Million	33,004 Added 12.68%	293,225 $11.5 Million
Q3 2019 Nov 01, 2019	BUY	$32.49 - $42.13 $337,960 - $438,236	10,402 Added 4.16%	260,221 $9.35 Million
Q2 2019 Aug 01, 2019	BUY	$36.98 - $41.52 $833,344 - $935,653	22,535 Added 9.91%	249,819 $10.8 Million
Q1 2019 Apr 30, 2019	BUY	$37.5 - $41.2 $47,212 - $51,870	1,259 Added 0.56%	227,284 $9.65 Million
Q4 2018 Feb 06, 2019	BUY	$38.47 - $43.86 $321,532 - $366,581	8,358 Added 3.84%	226,025 $9.87 Million
Q3 2018 Oct 29, 2018	SELL	$34.47 - $41.81 $481,752 - $584,336	-13,976 Reduced 6.03%	217,667 $9.59 Million
Q2 2018 Jul 27, 2018	SELL	$32.98 - $35.16 $677,178 - $721,940	-20,533 Reduced 8.14%	231,643 $8.4 Million
Q1 2018 May 11, 2018	SELL	$31.91 - $37.02 $338,820 - $393,078	-10,618 Reduced 4.04%	252,176 $8.95 Million
Q4 2017 Jan 31, 2018	SELL	$33.26 - $35.29 $450,207 - $477,685	-13,536 Reduced 4.9%	262,794 $9.52 Million
Q3 2017 Nov 02, 2017	BUY	$31.0 - $34.15 $8.57 Million - $9.44 Million	276,330	276,330 $9.87 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.

Account

Cullen/Frost Bankers, Inc. Pfizer Inc Transaction History